BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 16243320)

  • 1. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.
    Shen Q; Li W; Lin Y; Katsumi H; Okada N; Sakane T; Fujita T; Yamamoto A
    J Pharm Pharmacol; 2008 Dec; 60(12):1633-41. PubMed ID: 19000368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
    Song KH; Fasano A; Eddington ND
    Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
    Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
    Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between lipophilicity of BCS class III and IV drugs and the functional activity of peroral absorption enhancers.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):870-3. PubMed ID: 16182296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amphotericin B and cholera toxin on intestinal transport in the rat. An in vivo model for the effects of dihydroxy bile acids and fatty acids on intestinal transport.
    Ammon HV; Walter LG; Loeffler RF
    J Lab Clin Med; 1983 Oct; 102(4):509-21. PubMed ID: 6413628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeability characteristics of piperine on oral absorption--an active alkaloid from peppers and a bioavailability enhancer.
    Khajuria A; Zutshi U; Bedi KL
    Indian J Exp Biol; 1998 Jan; 36(1):46-50. PubMed ID: 9536651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction.
    Jin MJ; Han HK
    J Food Sci; 2010 Apr; 75(3):H93-6. PubMed ID: 20492299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
    Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
    J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
    González-Alvarez I; Fernández-Teruel C; Casabó-Alós VG; Garrigues TM; Polli JE; Ruiz-García A; Bermejo M
    Biopharm Drug Dispos; 2007 Jul; 28(5):229-39. PubMed ID: 17410527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression.
    Han Y; Chin Tan TM; Lim LY
    Toxicol Appl Pharmacol; 2008 Aug; 230(3):283-9. PubMed ID: 18417181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the intestinal permeability of ciclosporin using the in situ technique in rats and the relevance of P-glycoprotein.
    Zakeri-Milani P; Valizadeh H; Islambulchilar Z; Damani S; Mehtari M
    Arzneimittelforschung; 2008; 58(4):188-92. PubMed ID: 18540481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
    Ohashi R; Kamikozawa Y; Sugiura M; Fukuda H; Yabuuchi H; Tamai I
    Drug Metab Dispos; 2006 May; 34(5):793-9. PubMed ID: 16455807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
    Panchagnula R; Bansal T; Varma MV; Kaul CL
    Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
    Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
    J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion.
    Li M; Si L; Pan H; Rabba AK; Yan F; Qiu J; Li G
    Int J Pharm; 2011 Jan; 403(1-2):37-45. PubMed ID: 20969937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound.
    Tong HH; Du Z; Wang GN; Chan HM; Chang Q; Lai LC; Chow AH; Zheng Y
    Int J Pharm; 2011 Feb; 404(1-2):148-58. PubMed ID: 21094233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.